Navigation Links
2 Tufts biomedical graduate students awarded HHMI research fellowships

BOSTON (August 14, 2013) The Howard Hughes Medical Institute has awarded two doctoral students from the Sackler School of Graduate Biomedical Sciences at Tufts University with 2013 International Student Research Fellowships. Seblewongel Asrat, from Ethiopia, studies the bacterium that causes Legionnaires' disease while Jennifer Nwankwo, from Nigeria, studies red blood cell dehydration in sickle cell disease. The HHMI fellowship program provides support for international pre-doctoral students who are conducting outstanding research in the biomedical and related sciences.

Asrat, a molecular microbiology student, seeks to understand how specific cells in the immune system inhibit replication of the bacterium that causes Legionnaires' disease, a severe form of pneumonia. She has identified a novel strategy that immune cells use to overcome pathogen attack. Her advisor is Ralph Isberg, Ph.D., Howard Hughes Medical Institute (HHMI) investigator and professor of molecular biology and microbiology at Tufts University School of Medicine (TUSM), and member of both the genetics and molecular microbiology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts. Asrat is in the MERGE-ID track (Medically-oriented Research in Graduate Education - Infectious Disease) program at the Sackler School. Her co-advisor in this program is Jennifer Chow, M.S., M.D., attending physician in infectious diseases at Tufts Medical Center as well as an assistant professor at TUSM.

Nwankwo studies sickle cell disease, a group of red blood cell disorders that include sickle cell anemia. She specifically studies the role of enzymes that cause red blood cell dehydration and cell adhesion critical events that lead to the painful crises that are the hallmark of sickle cell disease. Her goal is to identify enzymes that could be targeted by new drug treatments for the disorders. Nwankwo is a student in the Pharmacology & Experimental Therapeutics program at the Sackler School, advised by Athar Chishti, Ph.D., professor in the department of integrative physiology and pathobiology at TUSM and member of the cellular & molecular physiology; molecular microbiology; and pharmacology & experimental therapeutics program faculties at the Sackler School.

Asrat and Nwankwo are two of 42 international students selected to become 2013 HHMI International Student Research Fellows. Invited students must be in the third or fourth year of a Ph.D. program at a designated nominating institution.

"These highly-competitive fellowships support the training of students who are committed to high-quality research that advances science and human health. This honor reflects the excellence of their work and the dedication of our faculty to provide the best training possible for our students," said Naomi Rosenberg, Ph.D., dean of the Sackler School of Graduate Biomedical Sciences and vice dean for research at Tufts University School of Medicine.


Contact: Siobhan Gallagher
Tufts University, Health Sciences Campus

Related medicine news :

1. Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug
2. Lifespan/Tufts/Brown Center for AIDS Research renewed with $8.5 million NIH grant
3. NYU Professor Li named Pew Scholar in Biomedical Sciences
4. California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014
5. General Data Acquires Triangle Biomedical Sciences
6. Mariner Biomedical Announces Results From an Independent Laboratory Confirming Deter Insect Repellent™ Effectively Repels Mosquitoes for 6 Hours
7. BIDMCs Mark Andermann, Ph.D., receives Smith Family Foundation Biomedical Research Award
8. ASU, Phoenix Childrens Hospital expand biomedical research partnership
9. Twelfth annual Wiley Prize in Biomedical Sciences awarded
10. An open platform revolutionizes biomedical-image processing
11. Human embryos frozen for 18 years yield viable stem cells suitable for biomedical research
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: